Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Benign Psychomotor Epilepsy, Childhood

3,4-dihydroxyphenylacetic acid has been researched along with Benign Psychomotor Epilepsy, Childhood in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rocha, L1
Alonso-Vanegas, M1
Villeda-Hernández, J1
Mújica, M1
Cisneros-Franco, JM1
López-Gómez, M1
Zavala-Tecuapetla, C1
Frías-Soria, CL1
Segovia-Vila, J1
Borsodi, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The BrainDrugs-Epilepsy Study: A Prospective Open-label Cohort Precision Medicine Study in Epilepsy[NCT05450822]550 participants (Anticipated)Observational2022-02-18Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Benign Psychomotor Epilepsy, Childhood

ArticleYear
Dopamine abnormalities in the neocortex of patients with temporal lobe epilepsy.
    Neurobiology of disease, 2012, Volume: 45, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Dopamine; Epilepsy, Temporal Lobe; Female; Homovanillic Acid;

2012